Showing 1591-1600 of 2839 results for "".
- GLP-1 Demand Holds Steady in Aesthetic Clinics Despite Regulatory Shiftshttps://modernaesthetics.com/news/glp-1-demand-holds-steady-in-aesthetic-clinics-despite-regulatory-shifts/2483599/Despite regulatory uncertainty and reported shortages, aesthetic practices continue to experience high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, according to a report released by Guidepoint Qsight on October 1, 2025.
- New Serum Targets Menopausal Skin Changes with Plant-Based Technologyhttps://modernaesthetics.com/news/new-serum-targets-menopausal-skin-changes-with-plant-based-technology/2483594/In recognition of Menopause Awareness Month, skinbetter science® announced the release of Mystro Revive Renewing Serum, a new topical product aimed at addressing visible skin changes associated with perimenopause and menopause.
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://modernaesthetics.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in
- Study Finds Abdominoplasty Can Help Improve Urinary Incontinence Symptomshttps://modernaesthetics.com/news/study-finds-abdominoplasty-can-help-improve-urinary-incontinence-symptoms/2483374/A new study published in Aesthetic Plastic Surgery reports that abdominoplasty may contribute to improvement in urinary incontinence symptoms. The study titled “Can Abdominoplasty Relieve Symptoms of Urinary Incontinence?” systematically reviewed the existing literature to evaluate the f
- Neuvian Skincare Granted US Patent for Dual-Peptide Complexhttps://modernaesthetics.com/news/neuvian-skincare-granted-us-patent-for-dual-peptide-complex/2483373/Neuvian Skincare has received a US patent for its dual-peptide formulation targeting inflammatory skin conditions such as wounds, scars, and eczema, according to a press release. The patent (No. 12,377,156 B2), issued for “Compositions and Methods for Treatment of Wounds and Inflammatory Skin Con
- iS Clinical Launches Hydrating Antioxidant Moisturizer Targeting Aging, Environmental Stresshttps://modernaesthetics.com/news/is-clinical-launches-hydrating-antioxidant-moisturizer-targeting-aging-environmental-stress/2483299/iS Clinical has introduced a new hydration-focused formulation, Daily Dynamic Hydrator, which is the company’s most advanced moisturizing product to date, according to a press release. The formulation is positioned as a 3-in-1 moisturizer that supports skin hydration, antioxidant protecti
- Allergan Aesthetics Launches Educational Campaign to Debunk Myths About HA Fillershttps://modernaesthetics.com/news/allergan-aesthetics-launches-educational-campaign-to-debunk-myths-about-ha-fillers/2483233/Allergan Aesthetics, an AbbVie company, has launched a new national campaign titled “Naturally You with Injectable Hyaluronic Acid Fillers,” aiming to counter widespread misinformation and educate both patients and healthcare providers on the safety and effectivenes
- Study Identifies Age-Related Collagen Changes in Vaginal Tissuehttps://modernaesthetics.com/news/study-identifies-age-related-collagen-changes-in-vaginal-tissue/2483214/A new study published in the Aesthetic Surgery Journal has identified key age-related changes in vaginal wall collagen that may contribute to the progressive degeneration of the female reproductive system. The study, titled “Age-Associated Collagen Remodeling in Vaginal Tissue: A
- Oral GLP-1 Hits Phase 3 Trial Targets; Regulatory Submissions Cominghttps://modernaesthetics.com/news/oral-glp-1-hits-phase-3-trial-targets-regulatory-submissions-coming/2483149/Eli Lilly and Company announced positive topline results from its Phase 3 ATTAIN-2 trial, showing that its investigational oral GLP-1 receptor agonist, orforglipron, achieved significant weight loss and improved cardiometabolic outcomes in adults with obesity or overweight status and type 2 diabe